GSK

News

CDC panel backs use of GSK, Pfizer’s RSV shots this year

Adults aged 60 and over in the US will be eligible for vaccinations with respiratory syncytial virus (RSV) vaccines from GSK or Pfizer later this year, if the Centers for

News

FDA delays review of GSK’s momelotinib for myelofibrosis

GSK won’t be hearing from the FDA this month about its marketing application for momelotinib as a treatment for myelofibrosis patients with anaemia after all.

News

GSK claims first EU approval for an RSV vaccine

GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu

News

After FDA nod, Pfizer joins GSK in RSV vaccine market

The FDA has approved Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, just a few weeks after a rival shot from GSK became the first to be cleared in th

News

SCOTUS won’t hear ‘skinny label’ lawsuit

The US Supreme Court has refused to look at the result of a federal lawsuit between GSK and Teva over so-called ‘skinny labels’ for generic drugs, despite a request from t

News

GSK chases down Pfizer in 5-in-1 meningitis jab contest

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a chall

CDC panel backs use of GSK, Pfizer’s RSV shots this year

FDA delays review of GSK’s momelotinib for myelofibrosis

GSK claims first EU approval for an RSV vaccine

After FDA nod, Pfizer joins GSK in RSV vaccine market

SCOTUS won’t hear ‘skinny label’ lawsuit

GSK chases down Pfizer in 5-in-1 meningitis jab contest

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

GSK

Editor's Picks